Chemoprevention and screening for lung cancer: changing our focus to former smokers
- PMID: 25454006
- DOI: 10.1016/j.cllc.2014.09.009
Chemoprevention and screening for lung cancer: changing our focus to former smokers
Abstract
Clinical trials of chemoprevention for lung cancer have yielded negative results, with suggested worsening of cancer incidence in those who continue to smoke. Continued smoking over age 55 is associated with decreased longevity and multiple comorbidities. It is possible that clinical trials focusing on former smokers in both prevention and screening trials will yield significant benefit, now masked by the population of continued smokers.
Keywords: Chemoprevention; Former smoker.
Copyright © 2015 Elsevier Inc. All rights reserved.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
